Human Papilloma Virus

waltky · Oct 20, 2015

Granny says, "Dat's right - get all three shots...

Study: Outreach increases HPV vaccination completion rate
Oct. 19, 2015 - Patients at safety net clinics received enhanced brochures and follow-up calls about finishing the vaccine's three shots.

Researchers found in a study of girls in Texas that a multicomponent outreach program helped increase the rate of completion of the three-shot human papillomavirus, or HPV, vaccine. HPV, a group of more than 200 related viruses, are the most common sexually transmitted infections in the United States. Among sexually active adults, more than 90 percent of men and 80 percent of women will be infected with HPV, according to the Centers for Disease Control and Prevention. Although some HPV infections do not carry symptoms, aside from genital warts, and can go away in one or two years, others persist and can cause several types of cancer, including cervical, head, neck and anal cancers.

The HPV vaccine has been controversial since its introduction because it is recommended for girls who are not yet sexually active.

Most people get HPV infections shortly after becoming sexually active for the first time, according to the National Cancer Institute. The HPV vaccine has been controversial since its introduction in 2006 because it was recommended for girls beginning at age 10 or 11 -- before many have become sexually active -- because of the danger for developing cervical cancer. "HPV vaccine delivery is challenging because of the dosing schedule and parental hesitation about vaccines," Dr. Celette Sugg Skinner, a professor at the University of Texas Southwestern, said in a press release. "Given these challenges, we must offer both education and vaccine opportunities at all healthcare visits."

Researchers at UT Southwestern worked with 814 girls between ages 11 and 18 at four safety-net clinics in Dallas County between 2010 and 2011. The vaccine has since been recommended for boys, but at the time of the study was still only recommended for girls. The study was conducted at publicly supported safety net clinics because rates of cervical cancer are higher among low-income populations, the researchers said. Participants were randomly assigned to receive either standard vaccine brochures or a multicomponent outreach program including an HPV-vaccine specific brochure, telephone calls to parents who declined, and follow-up calls for patients who were overdue for the second and third shots.

MORE
Click to expand...

waltky · Feb 22, 2016

HPV on the way down...

Study: HPV Drops 64 Percent in Teen Girls, Young Women
February 22, 2016 - Human papillomavirus has been known to cause cervical cancer as well as cancer of head and neck; drop attributed to vaccinations

Infections of the cancer-causing human papillomavirus, or HPV, have dropped by 64 percent among teenage girls and young women since a vaccine became available a decade ago, according to health officials. "We are continuing to see decreases in the HPV types that are targeted by the vaccine," said lead researcher Dr. Lauri Markowitz, a medical epidemiologist with the U.S. Centers for Disease Control and Prevention, in an interview with HealthDay. HPV has been known to cause cervical cancer as well as cancer of the head and neck.

Markowitz cautions that since it takes years for many of these cancers to develop, it will be a while before researchers know how much will be prevented by fewer infections. "We have seen declines in genital warts [caused by HPV] already," she said. "The next thing we expect to see is a decline in pre-cancers, then later on declines in cancer."

Lauren Fant, left, 18, braces for a shot of the HPV vaccine administered by nurse Stephanie Pearson in Marietta, Ga.

Still, researchers worry that not enough young people are being vaccinated, saying only 22 percent of boys between the ages of 13 and 17 have been vaccinated, while 42 percent of girls in the same age range have been vaccinated. Researchers said the reason perhaps is that many physicians do not strongly recommend the vaccine because it would require a potentially uncomfortable conversation about sex. The CDC recommends all children get vaccinated by age 12. "We could see greater declines in HPV-related disease if we had greater coverage," Markowitz said. "A very large percentage of cervical cancers could be prevented by the vaccine."

The CDC researchers used data from the U.S. National Health and Nutrition Examination Surveys to compare rates of HPV infection pre- and post-2006, when the vaccine was made available. Among girls aged 14-19, the infection rate dropped from 11.5 percent in 2003-2006 to 4.3 percent from 2009-2012. Similar rates of reduction were seen in women aged 20 to 24, showing a drop from 18.5 percent to just above 12 percent, the researchers said. "HPV vaccine is highly effective," Markowitz said. "We are seeing an impact of vaccination, but coverage rates are still too low. We need to see more coverage to see the full impact of the vaccine." The report was published online Feb. 22 in the journal Pediatrics.

http://www.voanews.com/content/mht-...4-percent-teen-girls-young-women/3202001.html
Click to expand...

Deckel · Feb 23, 2016

The correlation between HPV and certain cancers is so strong, the HPV vax should be classified as the first drug to prevent cancer.

RPA1 · Feb 23, 2016

It is interesting how in the past, morality substituted for keeping one healthy....Today it's technology which is decidedly amoral and probably more effective regarding physical health but maybe not so good at keeping one's moral health.

waltky · Jul 6, 2016

Granny says, "Dat's right - get all three doses ladies...

HPV vaccination reduces abnormal Pap tests
July 6, 2016 - Young women who get the recommended three doses of human papilloma virus (HPV) vaccine have fewer abnormal Pap tests than unvaccinated women and women who only get two doses, Canadian researchers say.

HPV vaccination is intended to prevent cervical cancer and abnormal cells that can lead to cancer, but how well its working among North American women remains unclear. Both HPV vaccination and cervical cancer screening are important to further reduce the incidence, morbidity, and mortality of cervical cancer, senior study author Dr. Huiming Yang from Alberta Health Services in Calgary told Reuters Health by email. The province of Alberta implemented a school-based HPV vaccination program for girls in 2008 and expanded it to include boys in 2014. The HPV vaccination program provides three doses of the vaccine over a six-month period. Yang and colleagues studied the impact on Pap test results eight years into this program.

The researchers analyzed data on 10,204 women, 56 percent of whom were unvaccinated and the rest had received at least one dose of HPV vaccine before having cervical cancer screening. Overall, 14.5 percent of women had abnormal Pap tests and 85.5 percent had normal tests. Most abnormal tests, nearly 94 percent, were low-grade abnormalities, but the rest were the high-grade abnormalities that could progress to cervical cancer. Less than 12 percent of women who had received at least three doses of the vaccine had abnormal Pap results, whereas 16 percent of unvaccinated women had abnormal tests. This translates into a 28 percent risk reduction with full HPV vaccination. The difference was even greater a 50 percent reduction in risk when only high-grade abnormalities were included, according to the results published in CMAJ.

Surprisingly, incomplete HPV vaccination with two or fewer doses of the vaccine was not associated with a lower risk of having an abnormal Pap test. "Our study shows that three doses HPV vaccination is very effective in reducing cervical cell abnormalities, particularly for high-grade lesions, but two does not appear to offer similar protection, Dr. Yang concluded. It is important to complete all scheduled doses of vaccine. "I found it interesting that young women in this study that received two doses of the quadrivalent vaccine had similar odds of having an abnormal Pap as those who had 0 doses, said Dr. Jacqueline M. Hirth from the University of Texas Medical Branch, Galveston, who has also studied the effect of HPV vaccination on cervical cancer screening among young women.

That result should be interpreted with caution, she told Reuters Health by email, since many of the young women in this sample were under 21 years of age and may not have been receiving routine Pap screenings. They may have actually gone to their providers for abnormal bleeding or other symptoms, which may have prompted them to receive Pap tests that would not have met the criteria for routine screenings, Hirth said. HPV vaccination in combination with cervical cancer screening according to guidelines is important for the prevention of cervical cancer, Hirth said, because the HPV vaccine does not protect against all high-risk HPV types. She added that it's important for women to receive all three doses of the HPV vaccine and to undergo cervical cancer screening regardless of vaccination history in order to reduce their risk of developing HPV-related cancers.

https://www.yahoo.com/news/hpv-vaccination-reduces-abnormal-pap-tests-175851409.html?ref=gs
Click to expand...

waltky · Jul 7, 2016

Who is dat lady?... Uncle Ferd thinks she's a Georgia peach...

HPV-related Cancers on Rise in US
July 07, 2016 - Cancer associated with the human papilloma virus (HPV) is on the rise, according to a study released by the U.S. Centers for Disease Control and Prevention.

The centers said from 2008 to 2012, there were about 39,000 annual cases of HPV-related cancers, which typically occur in the head, neck, genitals and reproductive organs. Thats up from 33,000 a year from 2004 and 2008.

Among the cases, there were 11,700 cases of cervical cancer and 12,600 cases of oropharyngeal cancer among men.

Lauren Fant, left, 18, braces for a shot of the HPV vaccine administered by nurse Stephanie Pearson in Marietta, Georgia

Of the 39,000 cases, the CDC says 28,500 cases could have been prevented by the HPV vaccine. The vaccine is available to girls and boys starting at the age of 11.

http://www.voanews.com/content/mht-hpv-related-cancers-on-the-rises-cdc/3408047.html
Click to expand...

waltky · Apr 7, 2017

Granny said Uncle Ferd can have sex with dat woman - she done had her HPV shot...

CDC: 25 Percent of Men Infected with Cancer-causing HPV
April 06, 2017 - A cancer causing strain of the human papillomavirus, or HPV, has infected 25 percent of men and 20 percent of women in the United States, new statistics from the National Center for Health Statistics.

Furthermore, some 45 percent of men have a genital form of the virus. "Human papillomavirus (HPV) is the most common sexually-transmitted infection in the United States," the team at the NCHS, part of the Centers for Disease Control and Prevention, wrote. "Some HPV types can cause genital warts and are considered low risk, with a small chance for causing cancer. Other types are considered high risk, causing cancer in different areas of the body including the cervix and vagina in women, penis in men, and anus and oropharynx [mouth and throat] in both men and women."

Lauren Fant, left, 18, braces for a shot of the HPV vaccine administered by nurse Stephanie Pearson in Marietta, Georgia

The virus has been linked to head and neck cancer as well as cervical cancer. According to NBC News, doctors think about 70 percent of head and neck cancers are caused by HPV spread through oral sex. They add that by 2020, head and neck cancers will be more common than the cervical cancer caused by the virus. Roughly four percent of adults are infected with an oral, cancer causing strain of HPV. Men had a higher rate than women.

For people under 25, there is a vaccine that can defend against the cancer causing strains of HPV. Among older adults, the virus continues to be passed around. According to NBC, the FDA-approved vaccines are Cervarix and Gardasil. There are 109 known strains of HPV.

http://www.voanews.com/a/mht-cdc-25-percent-of-men-infected-with-cancer-hpv/3799111.html
Click to expand...

waltky · Apr 8, 2017

High-risk HPV—the types of the virus that can cause cancer...

The Best Way to Protect Your Kids From HPV
April 7, 2017 - Human papillomavirus (HPV), a sexually transmitted infection, is remarkably common, according to a new publication from the National Center for Health Statistics, part of the Centers for Disease Control and Prevention.

The report reveals that 25 percent of men and 20 percent of women ages 18 to 59 are infected with what's called high-risk HPV—the types of the virus that can cause cancer. Previous studies of just women put the prevalence closer to 15 percent. "That’s pretty startling," says Geraldine McQuillan, Ph.D., an infectious disease epidemiologist at the CDC and the lead author of the report. "People tend to ho-hum this whole thing, not think it’s really an issue. ... This is an infection that leads to cancer—it's important."

Just 15 years ago, sexually active adults had no reliable way to protect against HPV. But for young people today, the infection is preventable: The HPV vaccine, approved for girls and women in 2006 and boys and men in 2009, offers protection against the riskiest forms of the virus—ideally before people are ever exposed to it. The CDC recommends the vaccine for all adolescents. Yet most remain unvaccinated.

Research has shown that primary care physicians do not recommend the HPV vaccine as strongly as they do other adolescent vaccines—in large part because it takes longer to discuss, and doctors perceive parents as unsupportive of the vaccine for their kids. A consortium of National Cancer Institute-designated cancer centers recently (PDF) released a statement that called the low vaccination rates "a serious public health threat." "Every parent should take stock of these statistics," says Consumer Reports medical director Orly Avitzur, M.D. "The vaccine provides a window of opportunity to prevent HPV-related cancers in adulthood."

HPV: A Preventable Problem
Click to expand...

Log in or Sign up

Human Papilloma Virus

waltky Well-Known Member

waltky Well-Known Member

Deckel Well-Known Member Past Donor

RPA1 Well-Known Member Past Donor

waltky Well-Known Member

waltky Well-Known Member

waltky Well-Known Member

waltky Well-Known Member

Share This Page

Log in or Sign up

Human Papilloma Virus

waltky Well-Known Member

waltky Well-Known Member

Deckel Well-Known Member Past Donor

RPA1 Well-Known Member Past Donor

waltky Well-Known Member

waltky Well-Known Member

waltky Well-Known Member

waltky Well-Known Member

Share This Page

Useful Searches